David Holbrook - Profile and Investment Details

Investor Profile

David Holbrook is a Venture Capital, Private Equity Firm based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Chevin, Oxford PV, Medisyn Technologies, Spectromics, Beach Solutions, Eykona Medical, Cable-Sense, Exosect, Cambridge University, MitoRx Therapeutics, Arvia Technology, Global Silicon, Nano ePrint, Sarantel, Lein Applied DiagnosticsPowerOasis, ApaTech, DCT, Arago Technology, DataLase, Bioxydyn, Worldwide Healthcare Trust plc, Eleksen Group Plc, Ai2 UK, Renephra, Powerlase Photonics, Onyvax Limited, . Over time, David Holbrook has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Holbrook is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Clean Tech, Health Care, Telecommunications, Cybersecurity, Wellness, Fundraising, Investment Management, Infrastructure, Energy, Life Science, Water Tech, Portfolio Management, Medical Technologies, Information Technology (IT), Finance, Manufacturing, Biotechnology, Food and Beverage, Capital Raising, Consulting, Utilities, Health Diagnostics, Translation Technology, Oil and Gas, Nanotechnology, Renewable Energy, Medical, Web Hosting, B2B, Financial Advisory, Recycling, Risk Management may find it worthwhile to explore potential connections with David Holbrook, as their portfolio suggests a familiarity and interest in this area.

Understanding David Holbrook’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.